Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Glycemic control is fundamental in the management of diabetes mellitus .If lifestyle
intervention and full tolerated doses of one or two oral glucose lowering drugs (OGLDs) fail
to achieve or sustain glycemic goals, insulin should be initiated. New insulin analogs are
generated to improve glycemic control .New insulin analogs are generated to improve glycemic
control,However, the cost of these analogs is a major problem .The aim of this piggy back
evaluation was to assess the effect of BIAsp 30 versus NPH plus regular human insulin on
metabolic control as well as its cost-effectiveness in people with type 2 diabetes in the
Iranian setting.